Gamma-Glutamyl Transferase (GGT) Test
The GGT test measures serum gamma-glutamyl transferase, a hepatobiliary enzyme sensitive to cholestasis, alcohol, and enzyme-inducing drugs. Its principal use is confirming the hepatobiliary source of a raised alkaline phosphatase, since GGT is not present in bone. It is sensitive but non-specific and is interpreted alongside the wider liver panel.
1
Biomarkers
Blood (serum)
Sample
1–3 business days
Turnaround
No
Fasting
What is the GGT test?
The GGT Test measures serum gamma-glutamyl transferase, a hepatobiliary enzyme that rises in cholestasis, alcohol use, and enzyme-inducing drug exposure. Its principal clinical role is to confirm the hepatobiliary origin of biochemical abnormalities, most usefully in distinguishing the source of an elevated alkaline phosphatase. Within the liver assessment landscape, GGT is a sensitive but non-specific adjunct rather than a first-line screen. When alkaline phosphatase is elevated, a concurrently raised GGT confirms a hepatobiliary source and excludes a skeletal one, since GGT is not present in bone. GGT is also used to corroborate suspected alcohol-related liver involvement, to investigate cholestatic patterns alongside ALP and bilirubin, and as a marker that correlates with metabolic syndrome and cardiovascular risk. Because many common drugs and alcohol induce the enzyme, GGT is interpreted together with the wider liver panel and clinical history.
What does the GGT test measure?
Gamma-glutamyl transferase is a membrane-bound enzyme that catalyses the transfer of gamma-glutamyl groups and participates in glutathione metabolism and amino-acid transport. It is concentrated in hepatobiliary epithelium, particularly the canalicular membrane of hepatocytes and biliary epithelial cells, with additional expression in the kidney, pancreas, and intestine. Although renal tissue has the highest concentration, serum GGT is overwhelmingly hepatobiliary in origin. The enzyme is inducible by alcohol and several drugs, and circulating activity reflects synthesis and biliary epithelial turnover.
GGT is a sensitive but non-specific marker of hepatobiliary disease and is most valuable in clarifying the source of an elevated alkaline phosphatase. A raised GGT alongside a raised ALP points to a hepatobiliary rather than a skeletal origin. It is also a sensitive indicator of cholestasis, enzyme induction by alcohol or medication, and, increasingly, a marker associated with metabolic and cardiovascular risk. Its lack of specificity means it is interpreted in context rather than as a standalone diagnostic.
Why is the GGT test ordered?
- Clarification of an isolated raised alkaline phosphatase — a concurrent GGT elevation confirms a hepatobiliary rather than a skeletal source
- Investigation of a cholestatic liver enzyme pattern, interpreted alongside ALP, bilirubin, and transaminases
- Assessment of suspected alcohol-related liver involvement, where GGT is a sensitive marker of induction and recent intake
- Monitoring of patients on enzyme-inducing medications where hepatobiliary effect is being evaluated
- Evaluation of unexplained hepatobiliary symptoms — right upper quadrant discomfort, pruritus, or jaundice — as part of a liver workup
- Cardiometabolic risk profiling where GGT is assessed alongside metabolic markers given its association with metabolic syndrome and cardiovascular risk
- Follow-up of abnormal liver function tests to characterise the pattern and track response to intervention over time
Sample collection and turnaround
Sample type
Blood (serum)
Fasting required
No
Collection method
Venipuncture at patient service centre
Turnaround
1–3 business days
Collection notes
Document alcohol intake and any enzyme-inducing medications, as both materially affect GGT. No special preparation is required.
Specimen requirements
Minimum 0.5 mL serum. Separate serum from cells per Access Medical Laboratories protocol. Specimen stable refrigerated; follow Access Medical Laboratories transport guidelines.
What can affect GGT results?
Alcohol induces hepatic GGT synthesis, raising serum activity even with moderate intake and well before structural liver damage. GGT is among the most sensitive biochemical markers of recent alcohol use.
These drugs induce hepatic microsomal enzymes including GGT, raising serum levels independent of hepatobiliary disease. Medication history should be documented.
Non-alcoholic fatty liver disease and metabolic dysfunction are common causes of chronically elevated GGT, reflecting hepatic fat accumulation and associated oxidative stress.
Impaired bile flow upregulates GGT in biliary epithelium and releases the membrane-bound enzyme, producing marked elevations that parallel ALP.
Tobacco use is associated with modestly higher GGT levels, likely through oxidative stress and enzyme induction, and may contribute to borderline elevations.
GGT is typically higher in males and increases with body mass, so sex-specific reference intervals are required to avoid misclassification.
What do GGT results mean?
Elevated
Elevated GGT indicates hepatobiliary involvement — cholestasis, biliary obstruction, alcohol or drug induction, or fatty liver disease. A raised GGT with a raised ALP confirms a hepatobiliary source of the ALP. Very high values suggest cholestasis or significant alcohol-related or obstructive disease.
Normal
A normal GGT alongside a raised ALP supports a non-hepatic (often skeletal) source of the ALP. A normal GGT does not fully exclude liver disease, since some hepatocellular conditions affect transaminases more than GGT.
Reduced
Low GGT has no adverse clinical significance and is generally favourable. Markedly low values are associated with lower metabolic and cardiovascular risk in population studies.
Note: GGT is sensitive but highly non-specific — it rises with alcohol, many medications, and metabolic liver disease, so an isolated elevation rarely localises the cause on its own. It is most informative interpreted with ALP, bilirubin, and transaminases. Mild isolated elevations are common and frequently reflect alcohol intake or fatty liver rather than serious pathology.
Frequently asked questions
Its principal use is to confirm the hepatobiliary source of a raised alkaline phosphatase. Because GGT is not present in bone, a concurrent GGT elevation confirms a hepatobiliary origin while a normal GGT points to a skeletal source.
How to access the GGT test
The GGT reference page is free and open to all practitioners. Create a free practitioner account to see pricing, save tests to your list, and generate requisition forms. Verification takes 1–2 business days.
Create Free AccountAbout this page
Published: June 2, 2026
Last reviewed: June 2, 2026
- Whitfield JB. Gamma glutamyl transferase. Crit Rev Clin Lab Sci. (2001)
- Newsome PN, et al. Guidelines on the management of abnormal liver blood tests. Gut. (2018)
- Ruttmann E, et al. Gamma-glutamyltransferase as a risk factor for cardiovascular disease mortality. Circulation. (2005)
- Kunutsor SK, et al. Gamma-glutamyltransferase and risk of type 2 diabetes: systematic review and meta-analysis. Am J Epidemiol. (2014)
This content is for licensed healthcare practitioners only and does not constitute medical advice. Clinical decisions should be based on the full clinical picture and not on any single test result.
Related tests
gastrointestinal
ALT
The ALT test measures serum alanine aminotransferase, the most hepatocyte-specific aminotransferase, released during liver cell injury. It is the primary marker of hepatocellular damage, interpreted with AST, alkaline phosphatase, and bilirubin to classify liver injury pattern, screen for metabolic steatotic liver disease, and monitor hepatotoxic therapy.
gastrointestinal
AST
The AST test measures serum aspartate aminotransferase, an enzyme in liver, heart, and muscle released during cellular injury. It is a sensitive but non-specific marker of hepatocellular damage, interpreted with ALT to calculate the AST:ALT ratio — below one suggests steatotic or viral liver disease, above two suggests alcohol-related injury — and correlated with CK and troponin when non-hepatic…